PrivateSurgical/MedicalSingaporeSingapore

Biobot Surgical

Robotic transperineal prostate biopsy/ablation with MRI-ultrasound fusion imaging for precision targeting.

biobotsurgical.com
Private
Valuation
Unranked (no confirmed valuation)
Rank on board
$38.7M
Total raised
2007
Founded

Profile

SectorSurgical robots
Value chainIntegrator
FlagshipiSR'obot Mona Lisa
HeadquartersSingaporeSingapore
ValuationPrivate. Source: Urology Times

Regulatory record

FDA clearances: 7

First 12 Aug 2011, latest 21 Dec 2023. Every 510(k) and De Novo filed under the company's name.

  • iSR`obot Mona Lisa 2.0
    21 Dec 2023 · K232320 · Applicant: Biobot Surgical Pte., Ltd.
  • iSR’obot Mona Lisa 2.0
    22 Dec 2021 · K213411 · Applicant: Biobot Surgical Pte., Ltd.
  • iSR'obot Mona Lisa 1.0
    8 Jul 2021 · K203659 · Applicant: Biobot Surgical Pte., Ltd.
  • iSR'obot Biopsy Kit
    16 May 2017 · K163502 · Applicant: Biobot Surgical Pte., Ltd.
  • iSR'obot MRI-US Fusion
    6 Oct 2016 · K161109 · Applicant: Biobot Surgical Pte., Ltd.
  • ISR'OBOT MONA LISA
    7 Jun 2013 · K130944 · Applicant: Biobot Surgical Pte., Ltd.
Show 1 earlier clearances
  • ISROBOT MONA LISA
    12 Aug 2011 · K111347 · Applicant: Biobot Surgical Pte., Ltd.

Source: FDA 510(k) database via openFDA, searched by applicant name, with partners and spun-off businesses removed. PMA approvals are not listed here.

Peers in Surgical/Medical

Company data updated 2026-11-16. All robot companies →